Detecting Genetic Mosaicism in Cultures of Human Pluripotent Stem Cells

Stem Cell Reports

Volumn 7, Issue 5, 2016, Pages 998-1012

  Baker, Duncan ^a,b   Hirst, Adam J ^a   Gokhale, Paul J ^a   Juarez, Miguel A ^a   Williams, Steve ^b   Wheeler, Mark ^b   Bean, Kerry ^b   Allison, Thomas F ^a   Moore, Harry D ^a   Andrews, Peter W ^a   Barbaric, Ivana ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

detection methods; genetic changes; Human pluripotent stem cells; sensitivity

Indexed keywords

AMPLICON; ANEUPLOIDY; ARTICLE; CHROMOSOME 12P; CHROMOSOME 12Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 4P; CHROMOSOME BANDING PATTERN; CHROMOSOME LOSS; CHROMOSOME MOSAICISM; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DIPLOIDY; EMBRYO; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; KARYOTYPING; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL CULTURE; TRISOMY; CELL CULTURE TECHNIQUE; CELL LINE; CHROMOSOME 17; CHROMOSOME 20; COPY NUMBER VARIATION; CYTOLOGY; GENETIC VARIATION; HUMAN CHROMOSOME; KARYOTYPE; METABOLISM; MOSAICISM;

CELL CULTURE TECHNIQUES; CELL LINE; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 20; DNA COPY NUMBER VARIATIONS; GENETIC VARIATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPE; MOSAICISM; PLURIPOTENT STEM CELLS; POLYMERASE CHAIN REACTION; TRISOMY;

EID: 84994560200     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2016.10.003     Document Type: Article

References (32)

1. Amps, K., Andrews, P.W., Anyfantis, G., Armstrong, L., Avery, S., Baharvand, H., Baker, J., Baker, D., Munoz, M.B., Beil, S., et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat. Biotechnol. 29 (2011), 1132–1144.
2. Avery, S., Hirst, A.J., Baker, D., Lim, C.Y., Alagaratnam, S., Skotheim, R.I., Lothe, R.A., Pera, M.F., Colman, A., Robson, P., et al. BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures. Stem Cell Rep. 1 (2013), 379–386.
3. Baker, D.E., Harrison, N.J., Maltby, E., Smith, K., Moore, H.D., Shaw, P.J., Heath, P.R., Holden, H., Andrews, P.W., Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 25 (2007), 207–215.
4. Ballif, B.C., Rorem, E.A., Sundin, K., Lincicum, M., Gaskin, S., Coppinger, J., Kashork, C.D., Shaffer, L.G., Bejjani, B.A., Detection of low-level mosaicism by array CGH in routine diagnostic specimens. Am. J. Med. Genet. A. 140 (2006), 2757–2767.
5. Barbaric, I., Biga, V., Gokhale, P.J., Jones, M., Stavish, D., Glen, A., Coca, D., Andrews, P.W., Time-lapse analysis of human embryonic stem cells reveals multiple bottlenecks restricting colony formation and their relief upon culture adaptation. Stem Cell Rep. 3 (2014), 142–155.
6. Ben-David, U., Mayshar, Y., Benvenisty, N., Virtual karyotyping of pluripotent stem cells on the basis of their global gene expression profiles. Nat. Protoc. 8 (2013), 989–997.
7. Blum, B., Bar-Nur, O., Golan-Lev, T., Benvenisty, N., The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat. Biotechnol. 27 (2009), 281–287.
8. Cross, J., Peters, G., Wu, Z., Brohede, J., Hannan, G.N., Resolution of trisomic mosaicism in prenatal diagnosis: estimated performance of a 50K SNP microarray. Prenat. Diagn. 27 (2007), 1197–1204.
9. D'Hulst, C., Parvanova, I., Tomoiaga, D., Sapar, M.L., Feinstein, P., Fast quantitative real-time PCR-based screening for common chromosomal aneuploidies in mouse embryonic stem cells. Stem Cell Rep. 1 (2013), 350–359.
10. Draper, J.S., Smith, K., Gokhale, P., Moore, H.D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T.P., Thomson, J.A., Andrews, P.W., Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 22 (2004), 53–54.
11. Enver, T., Soneji, S., Joshi, C., Brown, J., Iborra, F., Orntoft, T., Thykjaer, T., Maltby, E., Smith, K., Abu Dawud, R., et al. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum. Mol. Genet. 14 (2005), 3129–3140.
12. Fazeli, A., Liew, C.G., Matin, M.M., Elliott, S., Jeanmeure, L.F., Wright, P.C., Moore, H., Andrews, P.W., Altered patterns of differentiation in karyotypically abnormal human embryonic stem cells. Int. J. Dev. Biol. 55 (2011), 175–180.
13. Gekas, J., van den Berg, D.G., Durand, A., Vallee, M., Wildschut, H.I., Bujold, E., Forest, J.C., Rousseau, F., Reinharz, D., Rapid testing versus karyotyping in Down's syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalities. Eur. J. Hum. Genet. 19 (2011), 3–9.
14. Gohring, G., Giagounidis, A., Busche, G., Hofmann, W., Kreipe, H.H., Fenaux, P., Hellstrom-Lindberg, E., Schlegelberger, B., Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide. Haematologica 96 (2011), 319–322.
15. Goldring, C.E., Duffy, P.A., Benvenisty, N., Andrews, P.W., Ben-David, U., Eakins, R., French, N., Hanley, N.A., Kelly, L., Kitteringham, N.R., et al. Assessing the safety of stem cell therapeutics. Cell Stem Cell 8 (2011), 618–628.
16. Harrison, N.J., Baker, D., Andrews, P.W., Culture adaptation of embryonic stem cells echoes germ cell malignancy. Int. J. Androl. 30 (2007), 275–281 discussion 281.
17. Hoebeeck, J., Speleman, F., Vandesompele, J., Real-time quantitative PCR as an alternative to Southern blot or fluorescence in situ hybridization for detection of gene copy number changes. Methods Mol. Biol. 353 (2007), 205–226.
18. Hook, E.B., Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use. Am. J. Hum. Genet. 29 (1977), 94–97.
19. Lefort, N., Feyeux, M., Bas, C., Feraud, O., Bennaceur-Griscelli, A., Tachdjian, G., Peschanski, M., Perrier, A.L., Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat. Biotechnol. 26 (2008), 1364–1366.
20. Martins-Taylor, K., Nisler, B.S., Taapken, S.M., Compton, T., Crandall, L., Montgomery, K.D., Lalande, M., Xu, R.H., Recurrent copy number variations in human induced pluripotent stem cells. Nat. Biotechnol. 29 (2011), 488–491.
21. Olariu, V., Harrison, N.J., Coca, D., Gokhale, P.J., Baker, D., Billings, S., Kadirkamanathan, V., Andrews, P.W., Modeling the evolution of culture-adapted human embryonic stem cells. Stem Cell Res. 4 (2010), 50–56.
22. Olde Nordkamp, L., Mellink, C., van der Schoot, E., van den Berg, H., Karyotyping, FISH, and PCR in acute lymphoblastic leukemia: competing or complementary diagnostics?. J. Pediatr. Hematol. Oncol. 31 (2009), 930–935.
23. Sandberg, A.A., Meloni, A.M., Suijkerbuijk, R.F., Reviews of chromosome studies in urological tumors. III. Cytogenetics and genes in testicular tumors. J. Urol. 155 (1996), 1531–1556.
24. Shaffer, L.G., McGowan-Jordan, J., Schmid, M., (eds.) ISCN 2103: An International System for Human Cytogenetic Nomenclature, 2013, S. Karger.
25. Taapken, S.M., Nisler, B.S., Newton, M.A., Sampsell-Barron, T.L., Leonhard, K.A., McIntire, E.M., Montgomery, K.D., Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat. Biotechnol. 29 (2011), 313–314.
26. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007), 861–872.
27. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., Jones, J.M., Embryonic stem cell lines derived from human blastocysts. Science 282 (1998), 1145–1147.
28. Valli, R., Marletta, C., Pressato, B., Montalbano, G., Lo Curto, F., Pasquali, F., Maserati, E., Comparative genomic hybridization on microarray (a-CGH) in constitutional and acquired mosaicism may detect as low as 8% abnormal cells. Mol. Cytogenet., 4, 2011, 13.
29. Vogelstein, B., Kinzler, K.W., Digital PCR. Proc. Natl. Acad. Sci. USA 96 (1999), 9236–9241.
30. Werbowetski-Ogilvie, T.E., Bosse, M., Stewart, M., Schnerch, A., Ramos-Mejia, V., Rouleau, A., Wynder, T., Smith, M.J., Dingwall, S., Carter, T., et al. Characterization of human embryonic stem cells with features of neoplastic progression. Nat. Biotechnol. 27 (2009), 91–97.
31. Whale, A.S., Huggett, J.F., Cowen, S., Speirs, V., Shaw, J., Ellison, S., Foy, C.A., Scott, D.J., Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation. Nucleic Acids Res., 40, 2012, e82.
32. Yang, S., Lin, G., Tan, Y.Q., Zhou, D., Deng, L.Y., Cheng, D.H., Luo, S.W., Liu, T.C., Zhou, X.Y., Sun, Z., et al. Tumor progression of culture-adapted human embryonic stem cells during long-term culture. Genes Chromosomes Cancer 47 (2008), 665–679.